Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments

被引:142
作者
de Wit, E
Spronken, MIJ
Bestebroer, TM
Rimmelzwaan, GF
Osterhaus, ADME
Fouchier, RAM
机构
[1] Erasmus MC, Natl Influenza Ctr, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus MC, Dept Virol, NL-3000 DR Rotterdam, Netherlands
关键词
influenza A/PR/8/34; reverse genetics; chimeric viruses; fourth 3 ' nucleotide;
D O I
10.1016/j.virusres.2004.02.028
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A reverse genetics system for the generation of influenza virus A/PR/8/34 (NIBSC vaccine strain) from plasmid DNA was developed. Upon transfection of eight bidirectional transcription plasmids encoding the gene segments of A/PR/8/34 into 293T cells, virus titers in the supernatant were about 10(4) TCID50/ml. The production of A/PR/8/34 in 293T cells was compared to that of A/WSN/33, for which virus titers in the supernatant were 10(7)-10(8) TCID50/ml. Time-course analysis of virus production indicated that the differences in virus titers were due to reinfection of 293T cells by A/WSN/33 but not A/PR/8/34. Indeed, virus titers of A/PR/8/34 comparable to those of A/WSN/33 were achieved upon addition of trypsin to the culture medium of transfected cells. The production of chimeric viruses revealed that the difference in virus titers between A/PR/8/34 and A/WSN/33 are determined primarily by differences in the surface glycoproteins hemagglutinin and neuraminidase and the polymerase protein PB1. In conclusion, high-titer virus stocks of recombinant influenza A/PR/8/34 virus can be produced as well as virus stocks with much lower titers, but without the requirement of virus amplification through replication. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:155 / 161
页数:7
相关论文
共 18 条
  • [1] A novel influenza A virus mitochondrial protein that induces cell death
    Chen, WS
    Calvo, PA
    Malide, D
    Gibbs, J
    Schubert, U
    Bacik, I
    Basta, S
    O'Neill, R
    Schickli, J
    Palese, P
    Henklein, P
    Bennink, JR
    Yewdell, JW
    [J]. NATURE MEDICINE, 2001, 7 (12) : 1306 - 1312
  • [2] INTRODUCTION OF SITE-SPECIFIC MUTATIONS INTO THE GENOME OF INFLUENZA-VIRUS
    ENAMI, M
    LUYTJES, W
    KRYSTAL, M
    PALESE, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) : 3802 - 3805
  • [3] Rescue of influenza A virus from recombinant DNA
    Fodor, E
    Devenish, L
    Engelhardt, OG
    Palese, P
    Brownlee, GG
    García-Sastre, A
    [J]. JOURNAL OF VIROLOGY, 1999, 73 (11) : 9679 - 9682
  • [4] Distinct regions of influenza virus PB1 polymerase subunit recognize vRNA and cRNA templates
    González, S
    Ortín, J
    [J]. EMBO JOURNAL, 1999, 18 (13) : 3767 - 3775
  • [5] Identification of two separate domains in the influenza virus PB1 protein involved in the interaction with the PB2 and PA subunits: A model for the viral RNA polymerase structure
    Gonzalez, S
    Zurcher, T
    Ortin, J
    [J]. NUCLEIC ACIDS RESEARCH, 1996, 24 (22) : 4456 - 4463
  • [6] A novel mechanism for the acquisition of virulence by a human influenza A virus
    Goto, H
    Kawaoka, Y
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (17) : 10224 - 10228
  • [7] Human influenza A viral genes responsible for the restriction of its replication in duck intestine
    Hatta, M
    Halfmann, P
    Wells, K
    Kawaoka, Y
    [J]. VIROLOGY, 2002, 295 (02) : 250 - 255
  • [8] Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses
    Hatta, M
    Gao, P
    Halfmann, P
    Kawaoka, Y
    [J]. SCIENCE, 2001, 293 (5536) : 1840 - 1842
  • [9] A DNA transfection system for generation of influenza A virus from eight plasmids
    Hoffmann, E
    Neumann, G
    Kawaoka, Y
    Hobom, G
    Webster, RG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) : 6108 - 6113
  • [10] Eight-plasmid system for rapid generation of influenza virus vaccines
    Hoffmann, E
    Krauss, S
    Perez, D
    Webby, R
    Webster, RG
    [J]. VACCINE, 2002, 20 (25-26) : 3165 - 3170